BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25294164)

  • 1. Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.
    Logan M; Hawkins SM
    Clin Sci (Lond); 2015 Feb; 128(3):153-80. PubMed ID: 25294164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA and gynecologic cancers.
    Kanekura K; Nishi H; Isaka K; Kuroda M
    J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of miR-203 in endometrial carcinomas.
    Huang YW; Kuo CT; Chen JH; Goodfellow PJ; Huang TH; Rader JS; Uyar DS
    Gynecol Oncol; 2014 May; 133(2):340-5. PubMed ID: 24530564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of miRNA in endometrial cancer in the context of miRNA 205].
    Wilczyński M; Danielska J; Dzieniecka M; Malinowski A
    Ginekol Pol; 2015 Nov; 86(11):856-61. PubMed ID: 26817318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of microRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer.
    Wilczynski M; Danielska J; Domanska-Senderowska D; Dzieniecka M; Szymanska B; Malinowski A
    Acta Obstet Gynecol Scand; 2018 May; 97(5):560-569. PubMed ID: 29355888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.
    Kinoshita T; Hanazawa T; Nohata N; Okamoto Y; Seki N
    J Hum Genet; 2012 Sep; 57(9):556-63. PubMed ID: 22718022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs and their role in gynecological tumors.
    Torres A; Torres K; Maciejewski R; Harvey WH
    Med Res Rev; 2011 Nov; 31(6):895-923. PubMed ID: 20358579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in Ovarian Cancer.
    Katz B; Tropé CG; Reich R; Davidson B
    Hum Pathol; 2015 Sep; 46(9):1245-56. PubMed ID: 26216350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered MicroRNA expression in cervical carcinomas.
    Lee JW; Choi CH; Choi JJ; Park YA; Kim SJ; Hwang SY; Kim WY; Kim TJ; Lee JH; Kim BG; Bae DS
    Clin Cancer Res; 2008 May; 14(9):2535-42. PubMed ID: 18451214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical and diagnostic role of microRNAs in ovarian carcinoma.
    Davidson B; Tropé CG; Reich R
    Gynecol Oncol; 2014 Jun; 133(3):640-6. PubMed ID: 24713546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.
    Zavesky L; Jandakova E; Turyna R; Langmeierova L; Weinberger V; Minar L
    Neoplasma; 2016; 63(1):121-32. PubMed ID: 26639242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
    Karmon AE; Cardozo ER; Rueda BR; Styer AK
    Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles and clinical significance of microRNAs in cervical cancer.
    Wang F; Li B; Xie X
    Histol Histopathol; 2016 Feb; 31(2):131-9. PubMed ID: 26356641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated expression of long noncoding RNAs in gynecologic cancers.
    Hosseini ES; Meryet-Figuiere M; Sabzalipoor H; Kashani HH; Nikzad H; Asemi Z
    Mol Cancer; 2017 Jun; 16(1):107. PubMed ID: 28637507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
    Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
    Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells.
    Li JH; Xiao X; Zhang YN; Wang YM; Feng LM; Wu YM; Zhang YX
    Gynecol Oncol; 2011 Jan; 120(1):145-51. PubMed ID: 20947150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
    Koutsaki M; Spandidos DA; Zaravinos A
    Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in an oral cancer context - from basic biology to clinical utility.
    Gorenchtein M; Poh CF; Saini R; Garnis C
    J Dent Res; 2012 May; 91(5):440-6. PubMed ID: 22166582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular staging of gynecological cancer: What is the future?
    Binder PS; Prat J; Mutch DG
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):776-89. PubMed ID: 25934522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma.
    Wu W; Lin Z; Zhuang Z; Liang X
    Eur J Cancer Prev; 2009 Feb; 18(1):50-5. PubMed ID: 19077565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.